A quick questionnaire and a swab from the inside of her cheek, and Delaney Hilferty was pretty sure her duty was done. It was ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

Vernon Bernardino, an analyst from H.C. Wainwright, reiterated the Buy rating on GeoVax Labs (GOVX – Research Report). The associated ...

Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

It's been two years since Destiny Hannah received a bone marrow transplant to reverse her sickle cell disease. Once a patient ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

COLUMBUS, Ga. (WRBL) — 537 million adults worldwide live with the autoimmune disease Diabetes. Today is World Diabetes Day ...